56 related articles for article (PubMed ID: 11342196)
1. Clinical trials of Herceptin(R) (trastuzumab).
Baselga J
Eur J Cancer; 2001 Jan; 37 Suppl 1():18-24. PubMed ID: 11342196
[TBL] [Abstract][Full Text] [Related]
2. Clinical trials of Herceptin(trastuzumab).
Baselga J
Eur J Cancer; 2001 Jan; 37 Suppl 1():S18-24. PubMed ID: 11167087
[TBL] [Abstract][Full Text] [Related]
3. Lapatinib: a dual inhibitor of human epidermal growth factor receptor tyrosine kinases.
Medina PJ; Goodin S
Clin Ther; 2008 Aug; 30(8):1426-47. PubMed ID: 18803986
[TBL] [Abstract][Full Text] [Related]
4. Trastuzumab: new indication. Metastatic breast cancer, in combination with docetaxel: promising, but more evaluation is needed.
Prescrire Int; 2006 Feb; 15(81):3-5. PubMed ID: 16548094
[TBL] [Abstract][Full Text] [Related]
5. Carboplatin in combination therapy for metastatic breast cancer.
Perez EA
Oncologist; 2004; 9(5):518-27. PubMed ID: 15477636
[TBL] [Abstract][Full Text] [Related]
6. Trastuzumab: new preparation. May help some patients with breast cancer, but too many unknowns.
Prescrire Int; 2001 Aug; 10(54):102-5. PubMed ID: 11787463
[TBL] [Abstract][Full Text] [Related]
7. First-line, single-agent Herceptin(R) (trastuzumab) in metastatic breast cancer. a preliminary report.
Vogel C; Cobleigh MA; Tripathy D; Gutheil JC; Harris LN; Fehrenbacher L; Slamon DJ; Murphy M; Novotny WF; Burchmore M; Shak S; Stewart SJ
Eur J Cancer; 2001 Jan; 37 Suppl 1():25-29. PubMed ID: 11342197
[TBL] [Abstract][Full Text] [Related]
8. Durable and Complete Response to Herceptin Monotherapy in Patients with Metastatic Gastroesophageal Cancer.
Swofford BP; Dragovich T
Case Rep Oncol; 2017; 10(3):1098-1104. PubMed ID: 29430233
[TBL] [Abstract][Full Text] [Related]
9. Anti-HER2 therapy: how to use Herceptin in clinical practice.
Böhme C
Eur J Oncol Nurs; 2000 Mar; 4(Sa):30-6. PubMed ID: 12849615
[TBL] [Abstract][Full Text] [Related]
10. Trastuzumab therapy and the heart: palliation at what cost?
Aikat S; Francis GS
Congest Heart Fail; 2001; 7(4):188-190. PubMed ID: 11828162
[TBL] [Abstract][Full Text] [Related]
11. Safety of trastuzumab (Herceptin) during pregnancy: two case reports.
Goodyer MJ; Ismail JR; O'Reilly SP; Moylan EJ; Ryan CA; Hughes PA; O'Connor A
Cases J; 2009 Dec; 2():9329. PubMed ID: 20062589
[TBL] [Abstract][Full Text] [Related]
12. Choline ionic liquid enhances the stability of Herceptin® (trastuzumab).
Reslan M; Ranganathan V; Macfarlane DR; Kayser V
Chem Commun (Camb); 2018 Sep; 54(75):10622-10625. PubMed ID: 30177986
[TBL] [Abstract][Full Text] [Related]
13. Erratum: Herceptin as a single agent in the treatment of patients with metastatic breast cancer.
J Cancer Res Ther; 2016; 12(3):1211. PubMed ID: 28054540
[TBL] [Abstract][Full Text] [Related]
14. RNA nanostructures for targeted drug delivery and imaging.
Teodori L; Omer M; Kjems J
RNA Biol; 2024 Jan; 21(1):1-19. PubMed ID: 38555519
[TBL] [Abstract][Full Text] [Related]
15. Novel HER-2 Targeted Therapies in Breast Cancer.
Fernandes CL; Silva DJ; Mesquita A
Cancers (Basel); 2023 Dec; 16(1):. PubMed ID: 38201515
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal Antibodies and Antibody-drug Conjugates as Emerging Therapeutics for Breast Cancer Treatment.
Saini S; Gulati N; Awasthi R; Arora V; Singh SK; Kumar S; Gupta G; Dua K; Pahwa R; Dureja H
Curr Drug Deliv; 2024; 21(7):993-1009. PubMed ID: 37519200
[TBL] [Abstract][Full Text] [Related]
17. Dermatomyositis following Biosimilar Trastuzumab in a Breast Cancer Patient: A Case Report.
Moghimi M; Khodadadi K
Case Rep Oncol; 2021; 14(2):1134-1138. PubMed ID: 34413744
[TBL] [Abstract][Full Text] [Related]
18. A Companion Diagnostic With Significant Clinical Impact in Treatment of Breast and Gastric Cancer.
Jørgensen JT; Winther H; Askaa J; Andresen L; Olsen D; Mollerup J
Front Oncol; 2021; 11():676939. PubMed ID: 34367962
[TBL] [Abstract][Full Text] [Related]
19. The evolution of commercial drug delivery technologies.
Vargason AM; Anselmo AC; Mitragotri S
Nat Biomed Eng; 2021 Sep; 5(9):951-967. PubMed ID: 33795852
[TBL] [Abstract][Full Text] [Related]
20. Nanomaterials for Protein Delivery in Anticancer Applications.
Yau A; Lee J; Chen Y
Pharmaceutics; 2021 Jan; 13(2):. PubMed ID: 33503889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
